0.3000USD+20.00%Mkt Cap: 988490 USDP/E: —Last update: 2026-06-01
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a smal…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap988.49K USD
Enterprise Value-1.43M USD
Revenue (TTM)1.40M USD
Gross Profit1.40M USD
Net Income (TTM)-2.91M USD
Revenue/Share0.4370 USD
Last Price0.3000 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.10
PEG—
EV/EBITDA—
EV/Revenue-1.02
P/S0.70
P/B0.82
EPS (TTM)-0.52
EPS (Forward)-3.14
52W Range
0.150018% of range0.9699
52W High0.9699 USD
52W Low0.1500 USD
Profitability
Gross Margin100.00%
Oper. Margin-149.22%
EBITDA Margin0.00%
Profit Margin-207.19%
ROE-158.79%
ROA-99.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.83M USD
CapEx (TTM)—
FCF Margin-51.24%
FCF Yield-72.78%
Net Debt-2.42M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.94
Quick Ratio1.90
Book Value/Sh0.3640 USD
Cash/Share0.7340 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:75
Split DateApr 26, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.29M
Float2.85M
Insiders20.64%
Institutions7.02%
Short Interest
Short Ratio0.7d
Short % Float2.83%
Short % Out.2.83%
Shares Short59.70K
Short (prev mo.)154.91K
Technical
SMA 500.4166 (-28.0%)
SMA 2000.5463 (-45.1%)
Beta-0.08
S&P 52W Chg27.94%
Avg Vol (30d)3.55K
Avg Vol (10d)3.74K
Technical Indicators
RSI (14)34.7
MACD-0.0652
MACD Signal-0.0434
MACD Hist.-0.0219
BB Upper0.6846 USD
BB Middle0.3945 USD
BB Lower0.1044 USD
BB Width147.07%
ATR (14)0.0643 USD
Vol Ratio (20d)0.29x